(E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one

C25H27ClN2O8S — CID 19074386

IUPAC(E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one
SMILESO=C(O)/C=C/C(=O)O.O=C1c2ccccc2CS(=O)(=O)N1C(CCN1CCOCC1)c1ccc(Cl)cc1
InChIInChI=1S/C21H23ClN2O4S.C4H4O4/c22-18-7-5-16(6-8-18)20(9-10-23-11-13-28-14-12-23)24-21(25)19-4-2-1-3-17(19)15-29(24,26)27;5-3(6)1-2-4(7)8/h1-8,20H,9-15H2;1-2H,(H,5,6)(H,7,8)/b;2-1+
InChIKeyNIIKGVQFJHNTCA-WLHGVMLRSA-N
MW551.02 g/mol
LogP2.80
Rot. Bonds7

About (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one

(E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one (PubChem CID 19074386) has the molecular formula C25H27ClN2O8S and a molecular weight of 551.02 g/mol. Its IUPAC name is (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one.

Molecular Properties

Compound Name(E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one
PubChem CID19074386
Molecular FormulaC25H27ClN2O8S
Molecular Weight551.02 g/mol
Exact Mass550.12
IUPAC Name(E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one
SMILESO=C(O)/C=C/C(=O)O.O=C1c2ccccc2CS(=O)(=O)N1C(CCN1CCOCC1)c1ccc(Cl)cc1
InChIInChI=1S/C21H23ClN2O4S.C4H4O4/c22-18-7-5-16(6-8-18)20(9-10-23-11-13-28-14-12-23)24-21(25)19-4-2-1-3-17(19)15-29(24,26)27;5-3(6)1-2-4(7)8/h1-8,20H,9-15H2;1-2H,(H,5,6)(H,7,8)/b;2-1+
InChIKeyNIIKGVQFJHNTCA-WLHGVMLRSA-N
XLogP2.80
TPSA141.52 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms37
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500551.02
LogP ≤ 52.80
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one?
The IUPAC name of (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one (CID 19074386) is (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one.
What is the SMILES notation for (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one?
The canonical SMILES for (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one is O=C(O)/C=C/C(=O)O.O=C1c2ccccc2CS(=O)(=O)N1C(CCN1CCOCC1)c1ccc(Cl)cc1.
What is the InChIKey of (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one?
The InChIKey is NIIKGVQFJHNTCA-WLHGVMLRSA-N. The full InChI is InChI=1S/C21H23ClN2O4S.C4H4O4/c22-18-7-5-16(6-8-18)20(9-10-23-11-13-28-14-12-23)24-21(25)19-4-2-1-3-17(19)15-29(24,26)27;5-3(6)1-2-4(7)8/h1-8,20H,9-15H2;1-2H,(H,5,6)(H,7,8)/b;2-1+.
What are the key properties of (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one?
(E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one has a molecular weight of 551.02 g/mol, XLogP of 2.80, 7 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-but-2-enedioic acid;3-[1-(4-chlorophenyl)-3-morpholin-4-ylpropyl]-2,2-dioxo-1H-2λ6,3-benzothiazin-4-one is sourced from PubChem (CID 19074386), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).